Northern Genesis Sponsor II LLC - Jan 12, 2021 Form 3 Insider Report for Embark Technology, Inc. (EMBK)

Role
10%+ Owner
Signature
Northern Genesis Sponsor II LLC, by Ian Robertson, Managing Member
Stock symbol
EMBK
Transactions as of
Jan 12, 2021
Transactions value $
$0
Form type
3
Date filed
9/21/2022, 09:48 AM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EMBK Common Stock 10.4M Jan 12, 2021 By Northern Genesis Sponsor II LLC F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EMBK Warrant Jan 12, 2021 Common Stock 5.97M $11.50 By Northern Genesis Sponsor II LLC F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes up to 1,350,000 shares that may be forfeited if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
F2 The shares and warrants are owned directly by the Issuer's sponsor, Northern Genesis Sponsor II LLC (the "Sponsor"). Ian Robertson, the Issuer's Chief Executive Officer and Director, is one of the managing members of the Sponsor. Mr. Robertson disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein.
F3 Each warrant will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination or January 15, 2022.
F4 Each warrant will expire five years after the completion of the Issuer's initial business combination.
F5 Includes warrants which, prior to the effective date of the registration statement relating to the Issuer's initial public offering, the Issuer's Sponsor irrevocably committed to purchase. The purchase of these warrants is being made on a private placement basis and will be consummated simultaneously with the consummation of the Issuer's initial public offering. Does not include up to 720,000 additional warrants which the Issuer's Sponsor irrevocably committed to purchase in the event the underwriters in the Issuer's initial public offering exercise the over-allotment option in full. Each warrant entitles the holder to purchase one share of the Issuer's common stock at a price of $11.50 per share, subject to adjustment.

Remarks:

Inadvertently late filing.